Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Sep-24 4:17 PM View:  | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Aug-24 | Grant | 647 | $8.69 | $5,622.43 | < 1% 74.69K to 75.33K | |
| 25-Jun-24 4:39 PM View: | McKee Amy E Director | BioCryst Pharmaceuticals Inc. (BCRX) | 24-Jun-24 | Sale | 8,600 | $6.32 | $54,352.00 | (24%) 36.43K to 27.83K | |
| 17-Jun-24 4:31 PM View: | Sanders MacHelle Director | BioCryst Pharmaceuticals Inc. (BCRX) | 17-Jun-24 | Sale | 4,689 | $6.00 | $28,134.00 | (14%) 32.43K to 27.74K | |
| 14-Jun-24 4:25 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Jun-24 | Sale | 6,698 | $6.11 | $40,924.80 | (11%) 59.55K to 52.85K | |
| 14-Jun-24 4:30 PM View: | McKee Amy E Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 23% 29.61K to 36.43K | |
| 14-Jun-24 4:25 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 13% 52.73K to 59.55K | |
| 14-Jun-24 4:27 PM View: | Hutson Nancy J Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 8% 86.82K to 93.64K | |
| 14-Jun-24 4:20 PM View: | Aselage Steve Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 10% 65.84K to 72.66K | |
| 14-Jun-24 4:33 PM View: | Sanders MacHelle Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 27% 25.61K to 32.43K | |
| 14-Jun-24 4:28 PM View: | Levin Alan G Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 15% 44.95K to 51.77K | |
| 14-Jun-24 4:31 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 10% 67.87K to 74.69K | |
| 14-Jun-24 4:18 PM View: | Abercrombie George B Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 23% 29.61K to 36.43K | |
| 14-Jun-24 4:23 PM View: | Galson Steven K Director | BioCryst Pharmaceuticals Inc. (BCRX) | 12-Jun-24 | Grant | 6,820 | -- | -- | 13% 51.55K to 58.37K | |
| 03-Jun-24 4:29 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-24 | Grant | 870 | $6.46 | $5,620.20 | 1% 67.0K to 67.87K | |
| 03-Jun-24 4:33 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-24 | Grant | 870 | $6.46 | $5,620.20 | 2% 51.86K to 52.73K | |
| 31-May-24 4:25 PM View: | Levin Alan G Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-May-24 | Private Purchase | 7,861 | $6.36 | $49,996.00 | 21% 37.09K to 44.95K | |
| 29-May-24 4:16 PM View: | Aselage Steve Director | BioCryst Pharmaceuticals Inc. (BCRX) | 24-May-24 | Private Purchase | 2,500 | $6.40 | $16,000.00 | 4% 63.34K to 65.84K | |
| 22-May-24 7:21 AM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 20-May-24 | Private Purchase | 15,000 | $6.25 | $93,750.00 | 29% 52.0K to 67.0K | |
| 22-May-24 7:24 AM View: | Hutson Nancy J Director | BioCryst Pharmaceuticals Inc. (BCRX) | 20-May-24 | Private Purchase | 5,000 | $6.38 | $31,900.00 | 6% 81.82K to 86.82K | |
| 15-May-24 7:19 AM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-May-24 | Private Purchase | 36,300 | $5.57 | $202,191.00 | 16% 230.44K to 266.74K | |
| 15-May-24 7:17 AM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-May-24 | Private Purchase | 30,000 | $5.86 | $175,800.00 | 12% 242.14K to 272.14K | |
| 15-May-24 7:11 AM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 13-May-24 | Private Purchase | 5,000 | $5.53 | $27,650.00 | 2% 295.76K to 300.76K | |
| 15-May-24 7:08 AM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-May-24 | Private Purchase | 30,000 | $5.55 | $166,500.00 | 3% 1.14M to 1.17M | |
| 15-May-24 7:04 AM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 13-May-24 | Private Purchase | 30,000 | $5.47 | $164,100.00 | 11% 277.53K to 307.53K | |
| 15-May-24 7:14 AM View: | Galson Steven K Director | BioCryst Pharmaceuticals Inc. (BCRX) | 13-May-24 | Private Purchase | 21,940 | $5.49 | $120,451.00 | 74% 29.61K to 51.55K | |
| 02-Apr-24 4:21 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Mar-24 | Payment of Exercise | 7,525 | $5.08 | $38,227.00 | (3%) 249.66K to 242.14K | |
| 04-Mar-24 5:25 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-24 | Grant | 999 | $5.63 | $5,624.37 | 2% 51.0K to 52.0K | |
| 04-Mar-24 4:32 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-24 | Grant | 999 | $5.63 | $5,624.37 | 2% 50.86K to 51.86K | |
| 04-Jan-24 4:31 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | 2% 1.13M to 1.15M | |
| 04-Jan-24 4:31 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | (2%) 1.15M to 1.13M | |
| 20-Dec-23 4:42 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 5,580 | $6.05 | $33,759.00 | (2%) 255.24K to 249.66K | |
| 20-Dec-23 4:40 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 14,089 | $6.05 | $85,238.50 | (1%) 1.15M to 1.13M | |
| 20-Dec-23 4:33 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (< 1%) 296.02K to 293.54K | |
| 20-Dec-23 4:35 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (1%) 229.93K to 227.44K | |
| 20-Dec-23 4:38 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (< 1%) 277.01K to 274.53K | |
| 18-Dec-23 4:34 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 64,000 | -- | -- | 27% 236.04K to 300.04K | |
| 18-Dec-23 4:37 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 34,000 | -- | -- | 17% 201.4K to 235.4K | |
| 18-Dec-23 4:40 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 34,000 | -- | -- | 14% 248.85K to 282.86K | |
| 18-Dec-23 4:34 PM View: | Barnes Alane P Chief Legal Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 4,015 | $6.43 | $25,816.40 | (1%) 300.04K to 296.02K | |
| 18-Dec-23 4:47 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 51,000 | -- | -- | 25% 207.28K to 258.27K | |
| 18-Dec-23 4:43 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 127,500 | -- | -- | 12% 1.03M to 1.16M | |
| 18-Dec-23 4:37 PM View: | Doyle Anthony Chief Financial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 5,475 | $6.43 | $35,204.20 | (2%) 235.4K to 229.93K | |
| 18-Dec-23 4:40 PM View: | Gayer Charles K Chief Commercial Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 5,840 | $6.43 | $37,551.20 | (2%) 282.86K to 277.01K | |
| 18-Dec-23 4:47 PM View: | Thackray Helen M. Chief R&D Officer | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 3,031 | $6.43 | $19,489.30 | (1%) 258.27K to 255.24K | |
| 18-Dec-23 4:43 PM View: | Stonehouse Jon P President & CEO Director | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 13,592 | $6.43 | $87,396.60 | (1%) 1.16M to 1.15M | |
| 01-Dec-23 4:40 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-23 | Grant | 956 | $5.88 | $5,621.28 | 2% 49.91K to 50.86K | |
| 01-Dec-23 4:42 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-23 | Grant | 956 | $5.88 | $5,621.28 | 2% 50.04K to 51.0K | |
| 05-Sep-23 4:43 PM View: | Milano Vincent Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-23 | Grant | 791 | $7.11 | $5,624.01 | 2% 49.25K to 50.04K | |
| 05-Sep-23 4:41 PM View: | Heggie Theresa Director | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-23 | Grant | 791 | $7.11 | $5,624.01 | 2% 49.11K to 49.91K | |
| 15-Jun-23 4:37 PM View: | Sanders MacHelle Director | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jun-23 | Sale | 4,000 | $7.98 | $31,920.00 | (14%) 29.61K to 25.61K |
